explore -WSS

explore

author：fashion 2025-09-27 16:47:28 - browse：873

Primary care exam 01 — ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and Medtronic have run studies that showed renal denervation leads to a modest decrease in blood pressure. Adam Berry/Getty Images

The Food and Drug Administration approved a surgical system used to reduce blood pressure from Recor Medical, the company announced Wednesday. The treatment, called renal denervation, is controversial in the cardiology community due to its unclear efficacy.

Renal denervation is a treatment for patients who cannot manage standard doses of blood pressure medication — whether because the drugs aren’t effective enough for them, create overwhelming side effects, or become too cumbersome. The therapy, which is meant to be a one-time procedure, is administered via a catheter. Electrodes on the catheter then emit radiofrequency or ultrasound energy to block nerve signals from the kidneys that increase blood pressure.

The therapy, a simple procedure to reduce the blood pressure of millions of Americans, was once seen as a boon for cardiologists and device makers. But a large-scale clinical trial from Medtronic in 2014 called renal denervation’s efficacy into question, as it did not significantly reduce blood pressure compared to placebo treatments.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： Carvykti CAR

WSS

Christmas in the PICU brings some surprising joy

Bristol Myers buys into radiopharmaceuticals with RayzeBio

CDC: Cases of alpha

The mammogram wars are not over

Biden to sign 'historic' executive order on how US military handles sexual assault cases

Drinking less cuts risk of oral cavity, esophageal cancer: Report

knowledge

explore

entertainment

Bright Health sells Medicare Advantage business to Molina

What STAT readers think about the FDA and patient advocacy

The cancer drug shortage isn’t new — and neither are the solutions

Interest rates are at a 22

Activists slam private health insurers over coverage restrictions

Biden announces an advanced cancer research initiative

At least 13 dead in Texas as scorching temps continue

Timeline: Special counsel's probe into Trump's handling of classified documents

Heart attack and stroke risk calculators need revising

Behind warning on Apellis’s eye drug lies a conflict of interest

entertainment

An outrageous hospital charge: I paid $710 for an hour of babysitting

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

Three trends to watch in biotech in 2024

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

SEC charges former device maker CEO with $41 million fraud

An outrageous hospital charge: I paid $710 for an hour of babysitting

explore

focus

leisure time

entertainment